4.1 Article

Allelic expression analysis of the osteoarthritis susceptibility locus that maps to chromosome 3p21 reveals cis-acting eQTLs at GNL3 and SPCS1

期刊

BMC MEDICAL GENETICS
卷 15, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2350-15-53

关键词

Osteoarthritis; Genetic risk; Single nucleotide polymorphism; Allelic imbalance; Linkage disequilibrium

资金

  1. Arthritis Research UK
  2. NIHR Newcastle Biomedical Research Centre
  3. European Union Seventh Framework Program (D-BOARD) [305815]
  4. arcOGEN - Arthritis Research UK [18030]
  5. Medical Research Council [MR/K006312/1] Funding Source: researchfish
  6. Versus Arthritis [19824] Funding Source: researchfish
  7. MRC [MR/K006312/1] Funding Source: UKRI

向作者/读者索取更多资源

Background: An osteoarthritis (OA) susceptibility locus has been mapped to chromosome 3p21, to a region of high linkage disequilibrium encompassing twelve genes. Six of these genes are expressed in joint tissues and we therefore assessed whether any of the six were subject to cis-acting regulatory polymorphisms active in these tissues and which could therefore account for the association signal. Methods: We measured allelic expression using pyrosequencing assays that can distinguish mRNA output from each allele of a transcript single nucleotide polymorphism. We assessed RNA extracted from the cartilage and other joint tissues of OA patients who had undergone elective joint replacement surgery. A two-tailed Mann-Whitney exact test was used to test the significance of any allelic differences. Results: GNL3 and SPCS1 demonstrated significant allelic expression imbalance (AEI) in OA cartilage (GNL3, mean AEI = 1.04, p = 0.0002; SPCS1, mean AEI = 1.07, p < 0.0001). Similar results were observed in other tissues. Expression of the OA-associated allele was lower than that of the non-associated allele for both genes. Conclusions: cis-acting regulatory polymorphisms acting on GNL3 and SPCS1 contribute to the OA association signal at chromosome 3p21, and these genes therefore merit further investigation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Genome-wide association of phenotypes based on clustering patterns of hand osteoarthritis identify WNT9A as novel osteoarthritis gene

Cindy Germaine Boer, Michelle S. Yau, Sarah J. Rice, Rodrigo Coutinho de Almeida, Kathleen Cheung, Unnur Styrkarsdottir, Lorraine Southam, Linda Broer, Jeremy Mark Wilkinson, Andre G. Uitterlinden, Eleftheria Zeggini, David Felson, John Loughlin, Mariel Young, Terence Dante Capellini, Ingrid Meulenbelt, Joyce B. J. van Meurs

Summary: This study identified two novel genome-wide significant loci for OA in the thumb joints, with WNT9A identified as a possible novel causal gene for OA pathogenesis. Furthermore, several previously identified genetic loci for OA appear to confer risk for OA across multiple joints.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Review Orthopedics

Genetics of osteoarthritis

G. Aubourg, S. J. Rice, P. Bruce-Wootton, J. Loughlin

Summary: Osteoarthritis genetics has made significant progress through large-scale genome-wide association scans. Over 100 genetic risk variants associated with osteoarthritis have been identified, accounting for more than 20% of its heritability. These variants are mainly located in non-protein coding regions of the genome and regulate the expression of target genes. Epigenetic factors, particularly cartilage DNA methylation changes, are also correlated with some of these variants, suggesting a potential mediation of genetic effects on gene expression.

OSTEOARTHRITIS AND CARTILAGE (2022)

Article Rheumatology

Genetic and Epigenetic Interplay Within a COLGALT2 Enhancer Associated With Osteoarthritis

Yulia S. Kehayova, Emily Watson, J. Mark Wilkinson, John Loughlin, Sarah J. Rice

Summary: The study showed that the genotype at rs11583641 affects DNA methylation in cartilage, which in turn modulates the expression of COLGALT2, an enzyme involved in posttranslational glycosylation of collagens and plays a key role in OA susceptibility.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

Genetic and Epigenetic Fine-Tuning of TGFB1 Expression Within the Human Osteoarthritic Joint

Sarah J. Rice, Jack B. Roberts, Maria Tselepi, Abby Brumwell, Julia Falk, Charlotte Steven, John Loughlin

Summary: This study found that the OA risk SNP rs75621460 impacts TGFB1 expression by modulating the function of a gene enhancer. The research proposed a mechanism by which the SNP affects enhancer function, providing novel biological insights into one mechanism of OA genetic risk. This may help facilitate the development of future pharmacologic therapies for OA.

ARTHRITIS & RHEUMATOLOGY (2021)

Review Cell Biology

Cryptic splicing: common pathological mechanisms involved in male infertility and neuronal diseases

Saad Aldalaqan, Caroline Dalgliesh, Sara Luzzi, Chileleko Siachisumo, Louise N. Reynard, Ingrid Ehrmann, David J. Elliott

Summary: Recent findings highlight the essential role of RNA binding protein RBMXL2 in male meiosis, acting as a guardian of the transcriptome to prevent aberrant splice sites and maintain gene expression. This protective mechanism in meiosis may have evolved to ensure sperm production and male fertility, with implications for understanding neurodegenerative diseases like ALS and Alzheimer's.

CELL CYCLE (2022)

Review Biochemistry & Molecular Biology

Translating osteoarthritis genetics research: challenging times ahead

John Loughlin

Summary: The ultimate goal of molecular genetic studies of human diseases is to benefit patients through translation of discoveries. The lack of licensed disease-modifying therapies for diseases like osteoarthritis (OA) creates an urgent need. OA is a polygenic disease that primarily affects older individuals, and recent genome-wide studies have identified 52 novel association signals. Many of these signals involve effector genes that encode proteins targeted by drugs for other indications, indicating potential repurposing opportunities. This article discusses the potential for translating OA genetic data and whether the developmental origin of OA may limit its use for disease modification.

TRENDS IN MOLECULAR MEDICINE (2022)

Article Rheumatology

Neuropathic pain in the IMI-Open APPROACH knee osteoarthritis cohort: prevalence and phenotyping

Eefje Martine van Helvoort, Paco M. J. Welsing, Mylene P. Jansen, Willem Paul Gielis, Marieke Loef, Margreet Kloppenburg, Francisco Blanco, Ida K. Haugen, Francis Berenbaum, Anne-C Bay-Jensen, Christoph Ladel, Agnes Lalande, Jonathan Larkin, John Loughlin, Ali Mobasheri, Harrie Weinans, Floris Lafeber, Niels Eijkelkamp, Simon Mastbergen

Summary: Patients with osteoarthritis and a likely neuropathic pain component may represent a specific phenotype where joint damage is not the main cause of pain and disability. Those with a higher painDETECT score had less radiographic joint damage but impaired physical function compared to those with a lower painDETECT score. Severe pain was also found in joints other than the index knee, indicating the need for targeted treatment approaches.

RMD OPEN (2021)

Article Rheumatology

Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort

Eefje M. van Helvoort, Mylene P. Jansen, Anne C. A. Marijnissen, Margreet Kloppenburg, Francisco J. Blanco, Ida K. Haugen, Francis Berenbaum, Anne-Christine C. Bay-Jensen, Christoph Ladel, Agnes Lalande, Jonathan Larkin, John Loughlin, Ali Mobasheri, Harrie H. Weinans, Pawel Widera, Jaume Bacardit, Paco M. J. Welsing, Floris P. J. G. Lafeber

Summary: The IMI-APPROACH knee osteoarthritis study used machine learning to predict structural and pain progression. The study found that the predicted-progression scores were able to somewhat distinguish between actual progressors and non-progressors, with better prediction for pain progression than for structural progression.

RHEUMATOLOGY (2022)

Editorial Material Rheumatology

Toward Precision Medicine-Is Genetic Risk Prediction Ready for Prime Time in Osteoarthritis?

Michelle S. Yau, John Loughlin

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming

Faye A. H. Cooles, Jessica Tarn, Dennis W. Lendrem, Najib Naamane, Chung M. A. Lin, Ben Millar, Nicola J. Maney, Amy E. Anderson, Nishanthi Thalayasingam, Julie Diboll, Vincent Bondet, Darragh Duffy, Michael R. Barnes, Graham R. Smith, Sandra Ng, David Watson, Rafael Henkin, Andrew P. Cope, Louise N. Reynard, Arthur G. Pratt, John D. Isaacs

Summary: The interferon gene signature (IGS) in early, treatment naive rheumatoid arthritis (eRA) patients can negatively affect initial treatment response by causing sustained, epigenetically mediated increases in lymphocyte activation and proliferation. This highlights the importance of the IGS as a prognostic biomarker and suggests the rationale for targeting IFN-alpha in selected eRA patients.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative method

Zoe Paskins, Clare E. Farmer, Fay Manning, David A. Andersson, Tim Barlow, Felicity L. Bishop, Christopher A. Brown, Amanda Clark, Emma M. Clark, Debra Dulake, Malvika Gulati, Christine L. Le Maitre, Richard K. Jones, John Loughlin, Deborah J. Mason, Maura McCarron, Neil L. Millar, Hemant Pandit, George Peat, Stephen M. Richardson, Emma J. Salt, E. Jane Taylor, Linda Troeberg, Ruth K. Wilcox, Elspeth Wise, Colin Wilkinson, Fiona E. Watt

Summary: Involving research users in setting research priorities is crucial for patient-centered outcomes and maximizing value and impact. This study used the Child Health and Nutrition Research Initiative (CHNRI) method to identify key research priorities for musculoskeletal disorders. The priorities included developing new treatments, improving treatment targeting, early diagnosis, prevention, and understanding and management of pain.

LANCET RHEUMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Genetic risk of osteoarthritis operates during human skeletogenesis

Sarah J. Rice, Abby Brumwell, Julia Falk, Yulia S. Kehayova, John Casement, Eleanor Parker, Ines M. J. Hofer, Colin Shepherd, John Loughlin

Summary: This study investigates the activity and impact of genetic risk factors for osteoarthritis (OA) during human skeletogenesis. It shows that OA genetic risk is present during fetal development and is associated with allelic expression imbalances of specific genes. These findings are significant for understanding the pathogenesis of OA and developing pharmacological interventions.

HUMAN MOLECULAR GENETICS (2023)

Article Rheumatology

Mediation of the Same Epigenetic and Transcriptional Effect by Independent Osteoarthritis Risk-Conferring Alleles on a Shared Target Gene, COLGALT2

Yulia S. Kehayova, J. Mark Wilkinson, Sarah J. Rice, John Loughlin

Summary: This study aims to determine the target gene(s) and mechanism of action of the osteoarthritis (OA) locus. It was found that COLGALT2 is the target gene of this OA locus, and its expression is regulated by DNA methylation.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Osteoarthritis genetic risk acting on the galactosyltransferase gene COLGALT2 has opposing functional effects in articulating joint tissues

Yulia S. Kehayova, J. Mark Wilkinson, Sarah J. Rice, John Loughlin

Summary: Investigation reveals that DNA variants rs11583641 and rs1046934 decrease methylation status and increase expression of COLGALT2 in cartilage, marking risk for osteoarthritis. This study investigates if these effects are present in non-cartilaginous joint tissues.

ARTHRITIS RESEARCH & THERAPY (2023)

Article Rheumatology

Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effector gene of osteoarthritis genetic risk

Abby Brumwell, Guillaume Aubourg, Juhel Hussain, Eleanor Parker, David J. Deehan, Sarah J. Rice, John Loughlin

Summary: This study investigated a genetic locus associated with osteoarthritis and identified TMEM129 as a target gene at the locus. The genotype at rs11732213 was found to impact the DNA methylation at an enhancer, which in turn modulated TMEM129 expression. This research provides new insights into the susceptibility of osteoarthritis.

ARTHRITIS RESEARCH & THERAPY (2022)

暂无数据